Anterix Inc. — Director's Dealing 2024

Aug 8, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2024-08-06

Reporting Person: Guttman-McCabe Christopher (Chief Reg & Comm Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-08-06	Stock Option (Right to Buy)	$33.56	A	85000	Acquired	2034-08-06	Common Stock (85000)	Direct

Footnotes

F1: On March 27, 2024, the Compensation Committee of the Board of Directors of the Issuer granted the Reporting Person the stock options, at a strike price of $33.56 per share based upon the closing price of the Issuer's common stock on the Nasdaq on such date. In accordance with Nasdaq Listing Rules, the granted stock options were subject to, and were not exercisable until, the Issuer's stockholders approved an authorization of minimum shares of common stock underlying such stock options to exercise the referenced award. On August 6, 2024, stockholders of the Issuer approved Amendment No. 1 to the Issuer's 2023 Stock Plan, which authorized an additional 1,100,000 shares under the Issuer's 2023 Stock Plan and satisfied the award conditions of the Reporting Person's stock option award.

F2: The option shares will vest and become exercisable by the Reporting Person, if he is employed by the Issuer, on March 27, 2027, unless exercisable sooner in accordance with the terms of the award agreement or any other applicable agreement, arrangement or policy of the Issuer.